Anesthesia & Analgesia · 1994 · 75 citations · 0 references
Veterinary MedicineAnesthesiologyPharmacotherapyAnesthesiaPain ManagementPain MedicineAnalgesiaEpidural AnesthesiaInjectable AnesthesiaInjection TechniquesAdverse Drug EventsEpidural Catheter PlacementPharmacological Pain ReliefRefractory Angina TherapyThoracic Epidural AnalgesiaThoracic Epidural AnesthesiaTunneled Catheter CareTunneled Catheter Placement
Twenty patients with severe coronary artery disease (CAD) and refractory unstable angina who had sustained a recent myocardial infarction (n = 7) or who were considered as either inoperable (n = 10) or at severe operative risk (n = 3) were treated with high thoracic epidural anesthesia (TEA) via a tunneled epidural catheter for long-term self-use at home. They were instructed to use sublingual nitrates as their first treatment for angina and to inject 3-5 mL of bupivacaine (5 mg/mL) into the epidural catheter only for severe episodes. The epidural catheters were maintained for long periods (mean, 6 mo; longest treatment, 3.2 yr). Most patients expressed great satisfaction with the TEA treatment. The epidural bupivacaine injections induced complete pain relief within a short period. There were no severe adverse events induced by the treatment, and only one case of tachyphylaxis was documented. There was a decrease in the frequency of epidural injections with time from an average of 1.86 +/- 0.5 to 0.96 +/- 1.1 injections/d from the first to the last week of treatment (n = 18) (P < 0.001). This decrease was most evident when comparing the last week of TEA treatment in patients having TEA < 1 mo (n = 5) with patients having TEA > 6 mo (n = 5), an average of 2.00 +/- 0.47 vs 0.25 +/- 0.10 injections/d, respectively (P < 0.01). Seven patients had either coronary bypass surgery (n = 6) or spinal cord electrical stimulation (n = 1) after an average of 42 days of successful TEA treatment (range, 14-70 days).(ABSTRACT TRUNCATED AT 250 WORDS)